Veru Inc. (NASDAQ: VERU)
$0.95
+0.0024 ( +0.25% ) 791.3K
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.
Market Data
Open
$0.95
Previous close
$0.95
Volume
791.3K
Market cap
$139.30M
Day range
$0.92 - $0.97
52 week range
$0.36 - $1.92
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
nt | Quarterly Reports | 1 | Feb 15, 2024 |
8-k | 8K-related | 16 | Feb 08, 2024 |
def | Proxies and info statements | 4 | Jan 26, 2024 |
8-k | 8K-related | 12 | Jan 26, 2024 |
8-k | 8K-related | 17 | Dec 18, 2023 |
8-k | 8K-related | 33 | Dec 13, 2023 |
10-k | Annual reports | 93 | Dec 08, 2023 |
4 | Insider transactions | 1 | Nov 17, 2023 |
4 | Insider transactions | 1 | Nov 17, 2023 |
4 | Insider transactions | 1 | Nov 17, 2023 |